Conatus Pharmaceuticals Inc. buy melinda
Start price
02.04.19
/
50%
€10.46
Target price
30.10.19
€19.84
Performance (%)
-79.93%
End price
30.10.19
€2.10
Summary
This prediction ended on 30.10.19 with a price of €2.10. Massive losses of -79.93% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Conatus Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.336% | 4.366% | 21.868% | 63.911% |
| iShares Nasdaq 100 | 0.541% | 3.170% | 7.017% | 108.934% |
| iShares Nikkei 225® | 4.048% | 6.727% | 22.855% | 57.329% |
| iShares S&P 500 | 0.795% | 3.281% | 4.698% | 67.940% |
Comments by melinda for this prediction
In the thread Conatus Pharmaceuticals Inc. diskutieren
Secteur Recherche biotechnologique et médicale Agenda 13/04 | 16:00
Stopped prediction by melinda for Conatus Pharmaceuticals Inc.
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.61
11.12.18
11.12.18
€27.06
09.01.19
09.01.19
29.63%
09.01.19
09.01.19
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€35.45
06.12.17
06.12.17
€36.98
08.12.17
08.12.17
4.83%
08.12.17
08.12.17
Conatus Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.48
06.02.17
06.02.17
€49.61
30.03.17
30.03.17
5.62%
30.03.17
30.03.17